In 2005, Valverde et al. [21] described a database with 500 distinct RB1 mutations and more than 400 recurrences, of which 753 are germline mutations, 155 somatic mutations in RB tumors, and 24 somatic mutations in other types of tumors. This evidence concerns the gene RB1 and retinoblastoma.